Do Tirzepatide Drops Work — and Are They Even Legal in the UK?

Why can't tirzepatide simply be swallowed as a liquid?

This is the question at the heart of why drop formulations make no clinical sense. Tirzepatide is a large peptide molecule (structurally similar to a naturally occurring gut hormone) and like most peptides it is rapidly broken down by enzymes in the stomach and small intestine. Swallow it in any liquid form and the digestive tract does the same job it does on the protein in your breakfast: it dismantles it into fragments before it can reach the bloodstream.

That is precisely why the licensed medicine, tirzepatide, is given as a subcutaneous injection. Going under the skin bypasses the gut entirely, allowing the intact molecule to reach circulation and bind to the GIP and GLP-1 receptors that regulate appetite and blood sugar. There is no published clinical evidence that any oral drop formulation of tirzepatide achieves meaningful systemic absorption in humans. The MHRA has not approved one, and Eli Lilly (the manufacturer) does not produce one for the UK market.

Oral semaglutide does exist as a licensed tablet (Wegovy tablets, approved by the MHRA in June 2026) but it relies on a specific absorption-enhancing co-formulation technology called SNAC, taken on an empty stomach under tightly controlled conditions. Even then, bioavailability is lower than the injection. That technology does not apply to tirzepatide drops sold informally online.

What are these "tirzepatide drops" products actually selling?

If the molecule cannot survive oral administration, what is in the bottles? Honestly, nobody outside the seller knows, and that is the problem. Some products may contain nothing pharmacologically active at all. Others, based on MHRA enforcement intelligence, may contain unlicensed or mislabelled substances. The MHRA's ongoing crackdown on illegally traded weight-loss products (which led to the seizure of around 20 million doses of counterfeit and unlicensed products (roughly £45 million street value) and the raid of a counterfeit manufacturing site in Northampton in October 2025) shows how serious and widespread this market has become.

You can read more about what is actually known about products marketed under names like tirzepatide drops and why they circulate, but the short answer is that they exploit a search demand that the licensed injectable creates, without delivering its medicine. The MHRA invites reports of suspect sellers at Yellow Card, including products that appear to be unlicensed weight-loss medicines.

If something being sold as GLP-1 tirzepatide drops seems too convenient (no injection, no prescription, a price far below the market) those are all reasons to pause. Legitimate tirzepatide requires a prescription, a regulated supply chain, and a pharmacist who can be held accountable by the GPhC.

What does licensed tirzepatide actually involve, and who can access it?

Mounjaro is the MHRA-authorised tirzepatide product available in the UK. It is a once-weekly injection from a pre-filled KwikPen, started at 2.5mg (a dose chosen to let your system adjust gradually) and increased by a prescriber in roughly four-week steps up to a maximum of 15mg. In the SURMOUNT-1 clinical trial, involving thousands of adults with obesity, participants at the 15mg dose achieved an average body-weight reduction of around 20–21% over 72 weeks, as published in the New England Journal of Medicine. Those results were generated with the injected formulation, under clinical supervision, alongside dietary and activity changes, not with any oral product.

Privately, tirzepatide is available to adults with a BMI of 30 or above, or 27 or above alongside a weight-related condition such as high blood pressure, type 2 diabetes, or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. The eligibility picture is one a prescriber works through with you; BMI alone does not decide anything. You can explore weight-loss treatment options to understand the broader landscape before you consult.

On the cost side, private tirzepatide treatment varies by dose and provider. If you are researching Mounjaro drops as a cheaper alternative to the injection, it is worth knowing that there is no cheaper licensed alternative, just unregulated products making claims that the biology does not support. For context on what private treatment realistically costs and what any quoted price should include, the Mounjaro private prescription page covers that honestly. The bottom line: a small saving on an unlicensed product is not a saving if the product does nothing, or does something harmful.

What should you do if you have already bought tirzepatide drops?

Stop using them, and do not assume they are safe because you have not noticed an effect yet. If you have taken something and feel unwell (stomach pain, vomiting, an unusual reaction of any kind) contact NHS 111 or your GP. If a product was sold to you as a prescription medicine without any clinical assessment, it was sold outside the law.

Reading accounts of other people's experiences with these products, such as tirzepatide drops reviews, can be informative, but bear in mind that anecdote is not clinical evidence, and a placebo effect from any product is real. The absence of harm reported by one person tells you nothing about what you personally received.

If you want to explore whether genuine tirzepatide is right for you, the route is a proper clinical consultation. At nume, a real prescriber (not an automated system) reads your answers and medical context the same day. You can learn more about how we work or, when you are ready, speak to our prescribers about whether Mounjaro is suitable for you.